Evonik Industries (FRA:EVK) received a €24.00 ($27.91) target price from equities research analysts at Barclays in a note issued to investors on Monday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock. Barclays‘s price objective indicates a potential upside of 1.10% from the stock’s current price.
A number of other analysts have also commented on EVK. DZ Bank reiterated a “buy” rating on shares of Evonik Industries in a report on Tuesday, October 1st. Independent Research set a €25.00 ($29.07) price target on Evonik Industries and gave the stock a “neutral” rating in a report on Wednesday, August 7th. Credit Suisse Group set a €25.00 ($29.07) price target on Evonik Industries and gave the stock a “neutral” rating in a report on Thursday, October 10th. Deutsche Bank set a €38.00 ($44.19) target price on Evonik Industries and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, Morgan Stanley set a €34.00 ($39.53) target price on Evonik Industries and gave the company a “buy” rating in a research note on Monday, July 15th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of €28.90 ($33.61).
Shares of Evonik Industries stock opened at €23.74 ($27.60) on Monday. The business’s fifty day simple moving average is €22.95 and its 200 day simple moving average is €24.47. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Further Reading: How do taxes affect a CDs total return?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.